MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats

WMY. Mohamed, MA. Alazimi (Kuantan, Malaysia)

Meeting: 2019 International Congress

Abstract Number: 1712

Keywords: Aging

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: This study assessed the neuroprortective effects of combination of CoQ10 with vitamin E in Chronic Cerebral Hypoperfusion-induced neurodegeration (CCH-ND) model of rat.

Background: Alzheimer’s disease (AD) is the most common type of neurodegenerative diseases and the leading cause of dementia in elderly. Number of people with neurodegenerative diseases, is massively increasing. Currently, there is no prevention, no cure and no drug to slow down the progression of AD. Numerous evidences have revealed the presence of oxidative stress in the beginning and progression of AD. Therefore, the potential of using natural antioxidants for prevention and treatment of AD has attracted considerable attention. Coenzyme Q10 and Vitamin E have been reported as powerful antioxidants and used as protective agents for various illnesses. In spite of significant results in experimental studies, which used single antioxidant in AD models, administration of single antioxidant in AD patients has been failed. Therefore, an efficient strategy would be the use of combination of antioxidants in the treatment of Alzheimer’s disease to provide synergetic effects and enough antioxidant action without need of large and toxic doses of using single antioxidant.

Method: Acclimatization, 27 Sprague Dawley rats weighing 200-250 g were divided into six groups. Group A – sham control, Group B – 2VO, and Group C – 2VO+E (treated daily with Vit E, 100 mg/kg, orally following 2VO) Group D treated with Coenzyme Q10, group E treated with combination of CoQ10 and Vit E and group F treated with coconut oil as vehicle. On the 8th week, all the rats were tested by Morris water maze cognitive test and then euthanized and the hippocampi were isolated. Viable neuronal cell count in the hippocampal region was estimated. The Isoprostane F2 (F2-IsoPs) levels were deliberated in the brain homogenates to quantify the oxidative stress status.

Results: There was significant difference in neuronal cell death in 2VO group in comparison to the sham group. There was no statistically significant difference in neuroprotective effects of combination of vitamin E with CoQ10 and each one alone in chronic cerebral hypoperfusion-induced neurodegeneration in rat.

Conclusion: It is advisable that to use a combination of both vitamin E and CoQ10 for better protection against neurodegenerative disorders specially AD and PD.

To cite this abstract in AMA style:

WMY. Mohamed, MA. Alazimi. Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-combined-administration-of-coenzyme-q10-and-vitamin-e-in-chronic-cerebral-hypoperfusion-induced-neurodegeneration-in-rats/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-combined-administration-of-coenzyme-q10-and-vitamin-e-in-chronic-cerebral-hypoperfusion-induced-neurodegeneration-in-rats/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley